NFKB1 and neoplasm: Inflammatory TME is regulated by several cytokines [170], including interleukin (IL)-1 and IL-6, which promote cancer cell proliferation and invasion, increasing intracellular signaling by NF-kB, and cytokine receptor activation accelerates tumor progression [171].